Marrone Bio Innovations files for a $60 million IPO


Shutterstock photo

Marrone Bio Innovations, a producer of bio-based pest management and plant health products, filed on Monday with the SEC to raise up to $60 million in an initial public offering. The Davis, CA-based company, which was founded in 2006 and booked $8 million in sales for the 12 months ended March 31, 2013, plans to list on the NASDAQ under the symbol MBII. Marrone Bio Innovations initially filed confidentially in May 2012. Jefferies and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:








Research Brokers before you trade

Want to trade FX?





Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com